On September 4, 2025, the U.S. Food and Drug Administration (“FDA”) announced plans to begin releasing complete response letters (“CRLs”) “promptly” after it issues them to sponsors, rather than ...
FDA Commissioner Scott Gottlieb, M.D., has backed away from an earlier commitment to publish complete response letters (CRLs). Gottlieb talked up the prospect of releasing redacted versions of the ...
PROVIDENCE, RI – The US Food and Drug Administration’s (FDA) recently released trove of complete response letters (CRL) is a valuable resource for companies to understand the agency’s thinking on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results